Delivery Order SPE2DB22D2206-SPE2DB24FKE83

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 Firm Fixed Price Delivery Order contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 firm fixed-price delivery order is for the medical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a performance period running through November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 firm-fixed-price delivery order is for the supply of the specialty medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through November 13, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed price delivery order is for the medical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The $4,530.60 firm-fixed-price delivery order contract has a completion date of November 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a wide range of medical products,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,687.18, is for the delivery of the drug TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a completion date of April 25, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024. The $4,687.18 Firm Fixed Price Delivery Order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 Firm Fixed Price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has a period of performance through May 30, 2025 and was awarded on May 8, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm-fixed-price delivery order is for the supply of the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through June 5, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $11,717.95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a completion date of December 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKE83
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,530.60 firm-fixed price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has a period of performance through September 30, 2024 and does not include a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999 for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. The company also has an IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 for providing pharmaceutical and medical products. These IDCs enable government agencies to efficiently procure essential medical supplies from Amerisourcebergen, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/9/24, 2:08 PM